Controversies in cardiovascular MR imaging: Reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarction

Radiology

Volumn 265, Issue 1, 2012, Pages 23-32

  Arai, Andrew E ^a   Leung, Steve ^a   Kellman, Peter ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; FLUORESCENT DYE; GADOLINIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MICROSPHERE; WATER;

ACUTE HEART INFARCTION; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DOG; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART PROTECTION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; MYOCARDITIS; NONHUMAN; PARTICLE SIZE; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WATER CONTENT;

ANIMALS; CARDIAC-GATED IMAGING TECHNIQUES; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION;

EID: 84866631705     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112491     Document Type: Review

References (65)

1. Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 2001;104(24):2981-2989. (Pubitemid 33139113)
2. Aletras AH, Tilak GS, Natanzon A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113(15):1865-1870. (Pubitemid 43739398)
3. Kiricuta IC Jr, Simplǎ;ceanu V. Tissue water content and nuclear magnetic resonance in normal and tumor tissues. Cancer Res 1975;35(5):1164-1167.
4. Higgins CB, Herfkens R, Lipton MJ, et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 1983;52(1):184-188. (Pubitemid 13061350)
5. Tilak GS, Hsu LY, Hoyt RF Jr, Arai AE, Aletras AH. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol 2008;43(1):7-15.
6. García-Dorado D, Oliveras J, Gili J, et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res 1993;27(8):1462-1469. (Pubitemid 23265067)
7. Schwartz Longacre L, Kloner RA, Arai AE, et al. New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation 2011;124(10):1172-1179.
8. Klarich KW, Christian TF, Higano ST, Gibbons RJ. Variability of myocardium at risk for acute myocardial infarction. Am J Cardiol 1999;83(8):1191-1195. (Pubitemid 29183915)
9. Christian TF, Gibbons RJ, Clements IP, Berger PB, Selvester RH, Wagner GS. Estimates of myocardium at risk and collateral flow in acute myocardial infarction using electrocardiographic indexes with comparison to radionuclide and angiographic measures. J Am Coll Cardiol 1995;26(2):388-393.
10. Gibbons RJ. Tc-99m SPECT sestamibi for the measurement of infarct size. J Cardiovasc Pharmacol Ther 2011;16(3-4):321-331.
11. Mahaffey KW, Puma JA, Barbagelata NA, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo- controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol 1999;34(6):1711-1720.
12. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW; AMISTAD-II Investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTADII). J Am Coll Cardiol 2005;45(11):1775-1780. (Pubitemid 40779856)
13. Kim RJ, Albert TS, Wible JH, et al. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation 2008;117(5):629-637.
14. Reimer KA, Jennings RB. The changing anatomic reference base of evolving myocardial infarction: underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation. Circulation 1979;60(4):866-876. (Pubitemid 10239345)
15. Buja LM, Willerson JT. Abnormalities of volume regulation and membrane integrity in myocardial tissue slices after early ischemic injury in the dog: effects of mannitol, polyethylene glycol, and propranolol. Am J Pathol 1981;103(1):79-95. (Pubitemid 11100845)
16. Jennings RB, Schaper J, Hill ML, Steenbergen C Jr, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury: changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 1985;56(2):262-278. (Pubitemid 15131388)
17. Klem I, Kim RJ. Assessment of microvascular injury after acute myocardial infarction: importance of the area at risk. Nat Clin Pract Cardiovasc Med 2008;5(12):756-757.
18. Abdel-Aty H, Cocker M, Meek C, Tyberg JV, Friedrich MG. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol 2009;53(14):1194-1201.
19. Bragadeesh T, Jayaweera AR, Pascotto M, et al. Post-ischaemic myocardial dysfunction (stunning) results from myofibrillar oedema. Heart 2008;94(2):166-171. (Pubitemid 351211722)
20. Payne AR, Berry C, Kellman P, et al. Brightblood T(2)-weighted MRI has high diagnostic accuracy for myocardial hemorrhage in myocardial infarction: a preclinical validation study in swine. Circ Cardiovasc Imaging 2011;4(6):738-745.
21. Arai AE, Pantely GA, Anselone CG, Bristow J, Bristow JD. Active downregulation of myocardial energy requirements during prolonged moderate ischemia in swine. Circ Res 1991;69(6):1458-1469.
22. Natanzon A, Aletras AH, Hsu LY, Arai AE. Determining canine myocardial area at risk with manganese-enhanced MR imaging. Radiology 2005;236(3):859-866. (Pubitemid 41170848)
23. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36(6):1985-1991.
24. Christian TF, Aletras AH, Arai AE. Estimation of absolute myocardial blood flow during first-pass MR perfusion imaging using a dual-bolus injection technique: comparison to single-bolus injection method. J Magn Reson Imaging 2008;27(6):1271-1277. (Pubitemid 351770677)
25. Christian TF, O'Connor MK, Schwartz RS, Gibbons RJ, Ritman EL. Technetium-99m MIBI to assess coronary collateral flow during acute myocardial infarction in two closed-chest animal models. J Nucl Med 1997;38(12):1840-1846. (Pubitemid 28030909)
26. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985;312(14):932-936.
27. Berry C, Kellman P, Mancini C, et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging 2010;3(5):527-535.
28. Mewton N, Rapacchi S, Augeul L, et al. Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model. Basic Res Cardiol 2011;106(6):1247-1257.
29. Ugander MBP, Oki AJ, Chen B, et al. Quantitative T1-maps delineate myocardium at risk as accurately as T2-maps: experimental validation with microspheres. In: 2011 Scientific Sessions of the Society of Cardiovascular Magnetic Resonance and the EuroCMR. Nice, France, 2010.
30. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2- weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004;109(20):2411-2416. (Pubitemid 38679560)
31. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51(16):1581-1587. (Pubitemid 351508364)
32. Carlsson M, Ubachs JF, Hedström E, Heiberg E, Jovinge S, Arheden H. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging 2009;2(5):569-576.
33. Graham MM, Faris PD, Ghali WA, et al. Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort. Am Heart J 2001;142(2):254-261. (Pubitemid 32706283)
34. Wince WB, Kim RJ. Molecular imaging: T2-weighted CMR of the area at risk: a risky business? Nat Rev Cardiol 2010;7(10):547-549.
35. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100(19):1992-2002. (Pubitemid 29529292)
36. Kim RJ, Judd RM, Chen EL, Fieno DS, Parrish TB, Lima JA. Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction. Circulation 1999;100(2):185-192.
37. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343(20):1445-1453.
38. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts longterm improvement in contractile function. Circulation 2001;104(10):1101-1107. (Pubitemid 32830391)
39. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103(23):2780-2783. (Pubitemid 32550063)
40. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002;106(18):2322-2327. (Pubitemid 35244732)
41. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105(2):224-229. (Pubitemid 34084323)
42. Mahrholdt H, Wagner A, Parker M, et al. Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. J Am Coll Cardiol 2003;42(3):505-512. (Pubitemid 36951719)
43. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361(9355):374-379. (Pubitemid 36164969)
44. Matsumoto H, Matsuda T, Miyamoto K, Shimada T, Mikuri M, Hiraoka Y. Periinfarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction. JACC Cardiovasc Imaging 2011;4(6):610-618.
45. Arai AE. Gadolinium can depict area at risk and myocardial infarction: a double- edged sword? JACC Cardiovasc Imaging 2011;4(6):619-621.
46. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94(12):3318-3326. (Pubitemid 26427504)
47. Kramer CM, Rogers WJ Jr, Mankad S, Theobald TM, Pakstis DL, Hu YL. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 2000;36(6):1835-1840.
48. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104(23):2838-2842. (Pubitemid 33126660)
49. Judd RM, Kim RJ. Imaging time after Gd- DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2002;106(2):e6; author reply e6.
50. Sörensson P, Heiberg E, Saleh N, et al. Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography. J Cardiovasc Magn Reson 2010;12(1):25.
51. Friedrich MG, Kim HW, Kim RJ. T2-weighted imaging to assess post-infarct myocardium at risk. JACC Cardiovasc Imaging 2011;4(9):1014-1021.
52. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40(6):633-644. (Pubitemid 9191795)
53. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56(5):786-794. (Pubitemid 8235183)
54. Ubachs JF, Engblom H, Erlinge D, et al. Cardiovascular magnetic resonance of the myocardium at risk in acute reperfused myocardial infarction: comparison of T2- weighted imaging versus the circumferential endocardial extent of late gadolinium enhancement with transmural projection. J Cardiovasc Magn Reson 2010;12:18.
55. Fuernau G, Eitel I, Franke V, et al. Myocardium at risk in ST-segment elevation myocardial infarction comparison of T2-weighted edema imaging with the MR-assessed endocardial surface area and validation against angiographic scoring. JACC Cardiovasc Imaging 2011;4(9):967-976.
56. Versteylen MO, Bekkers SC, Smulders MW, et al. Performance of angiographic, electrocardiographic and MRI methods to assess the area at risk in acute myocardial infarction. Heart 2012;98(2):109-115.
57. Hsu LY, Ingkanisorn WP, Kellman P, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI. II. Clinical application of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23(3):309-314. (Pubitemid 43364056)
58. Hsu LY, Natanzon A, Kellman P, Hirsch GA, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI. I. Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23(3):298-308. (Pubitemid 43364055)
59. Simonetti OP, Finn JP, White RD, Laub G, Henry DA. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology 1996;199(1):49-57.
60. Aletras AH, Kellman P, Derbyshire JA, Arai AE. ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. Magn Reson Med 2008;59(2):229-235. (Pubitemid 351220085)
61. Ortiz-Pérez JT, Meyers SN, Lee DC, et al. Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. Eur Heart J 2007;28(14):1750-1758. (Pubitemid 47227100)
62. Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. JACC Cardiovasc Imaging 2009;2(7):825-831.
63. Hedström E, Engblom H, Frogner F, et al. Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species: implications for assessment of myocardial salvage. J Cardiovasc Magn Reson 2009;11:38.
64. Giri S, Chung YC, Merchant A, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009;11:56.
65. Arai AE, Epstein FH, Bove KE, Wolff SD. Visualization of aortic valve leaflets using black blood MRI. J Magn Reson Imaging 1999;10(5):771-777. (Pubitemid 29519780)